The Corby facility was nominated in several categories, including “Best Process Factory” and “Overall Best UK Factory.”
The awards evaluation highlighted Catalent’s ability to quickly introduce new customer products from the site. This was recently demonstrated by a packaging launch involving GlaxoSmithKline’s anti-viral product Relenza®, which has been recommended by a number of global health authorities for treatment of H1N1 influenza. The Corby team moved from preliminary discussion through design, implementation, validation, and into full production in just twelve weeks, helping GlaxoSmithKline meet increasing demand for the product.
Steve Facer, general manager of Catalent’s Corby site, said, “The rigorous assessment process for the awards have provided us a useful means to evaluate the progress we’ve made through our focus on continuous improvement. The High Commendation we received shows how far we’ve come, and is a testament to the commitment and effort of everyone on the Corby team.”
“Catalent is several years into its lean manufacturing journey, with several hundred Kaizen events completed and more than a thousand employees trained in lean and six sigma principles,” said Steve Leonard, Catalent’s Senior Vice President of Operations. “The team at Corby has embraced the principles of continuous improvement and operational excellence, as recognized by the commendation, and has translated those operating principles to real value for our customers and for their patients.”